Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-09-11-Speech-2-372-218"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-09-11"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"lt"^^xsd:language2
lpv:document identification number	"en.20120911.32.2-372-218"2
lpv:hasSubsequent	lp_eu:2012-09-11-Speech-2-372-2502
lpv:speaker	lp:Radvilė Morkūnaitė-mikulėnienė2
lpv:spokenAs	member; EPP (2009-07-14--2014-06-30)3 member; Delegation for relations with the United States (2009-09-16--2014-06-30)3 substitute; REGI (2012-01-19--2014-06-30)3 member; Delegation to the Parliamentary Assembly of the Union for the Mediterranean (2009-09-16--2014-06-30)3 member; ENVI (2012-01-19--2014-06-30)3 unknown; Tėvynės sąjunga - Lietuvos krikščionys demokratai (2009-07-14--2014-06-30)3
lpv:translated text	"Patient safety and proper information about medicines taken, as well as the safety of the medicines themselves, is one of the main objectives of EU public health policy. Practices show that abuse by drug manufacturers can lead to deaths when introducing medicines to the market or withdrawing medicines which are dangerous to human health. On the other hand, information leaflets provided to consumers must be clear and comprehensible. I therefore welcome the introduction of more stringent requirements and administrative procedures."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph